Acne Ultra Gel (Clindamycin / Niacinamide / Tretinoin) (30 mL)

Clindamycin Phosphate, Niacinamide, and Tretinoin: How They Work and Why They Matter

Clindamycin Phosphate is an antibiotic that helps fight certain bacterial infections by stopping bacteria from making proteins they need to grow. It’s mostly used to treat skin problems like acne, though scientists are still figuring out exactly how it helps. However, overusing it can lead to resistant bacteria and gut issues like colitis.

Niacinamide is a form of vitamin B3 that’s important for energy, skin repair, and reducing inflammation. Unlike its cousin, niacin, it doesn’t cause flushing or irritation, which makes it great for sensitive skin conditions like acne and rosacea. It’s a safe, widely used ingredient in creams and supplements.

Tretinoin is a vitamin A derivative that helps renew skin cells and improve the texture of damaged or aging skin. It’s commonly prescribed for acne and sun-damaged skin but is also used in certain blood cancers. By encouraging healthy cell growth, tretinoin helps clear clogged pores and reduce wrinkles, though it doesn’t directly fight bacteria. In cancer treatment, it helps immature blood cells grow properly but requires careful monitoring for serious side effects.

Clindamycin Phosphate, Niacinamide, and Tretinoin: Mechanisms and Clinical Relevance
Clindamycin Phosphate – Bacteriostatic Antibiotic for Targeted Use

Clindamycin is a lincosamide antibiotic that exerts its action by binding to the 23S RNA of the 50S ribosomal subunit, halting bacterial protein synthesis. It is primarily bacteriostatic, although bactericidal activity may occur at high concentrations or against particularly susceptible organisms.

Clindamycin is widely used to treat infections caused by anaerobic bacteria, some Gram-positive cocci, and conditions like acne vulgaris, although the precise mechanism for its acne-fighting effect is still not fully understood.

Resistance to clindamycin typically arises from mutations in ribosomal RNA, and cross-resistance exists between clindamycin, lincomycin, and sometimes macrolides and streptogramin B. For organisms resistant to macrolides but appearing susceptible to clindamycin, a D-zone test is recommended to detect inducible resistance.

A major risk with clindamycin is pseudomembranous colitis, usually due to Clostridium difficile overgrowth, which necessitates caution during prolonged or repeated use. Some bacterial strains (e.g., C. perfringens, B. fragilis) are showing increasing resistance, particularly post-treatment of bacterial vaginosis.

Niacinamide – Essential B3 Vitamin with Distinct Pharmacologic Identity

Niacinamide (nicotinamide) is the amide form of vitamin B3, a vital nutrient involved in numerous metabolic redox reactions. It functions through coenzymes NAD and NADP, which support energy production, glucose metabolism, and cellular repair.

As a vitamin, both niacin (nicotinic acid) and niacinamide are biochemically equivalent, but they differ in pharmacologic effects:

Nicotinic acid produces vasodilation and is used as a lipid-lowering agent, albeit with side effects like flushing, pruritus, and potential hepatotoxicity.

Niacinamide, however, does not cause flushing, does not lower lipid levels, and is better tolerated, making it useful for topical dermatologic applications, including treatment of acne, rosacea, and inflammatory skin conditions.

Niacinamide plays a critical role in cellular energy balance, DNA repair, and anti-inflammatory responses, and is well-tolerated both orally and topically, making it a popular ingredient in skincare and supplements.

Tretinoin – A Retinoid for Acne, Photodamage, and Cancer

Tretinoin (all-trans-retinoic acid) is a vitamin A derivative that works by binding to retinoic acid receptors (RARs), modifying gene expression and promoting epithelial cell turnover and differentiation. Tretinoin affects RAR-alpha, -beta, and -gamma, which are variably distributed across tissues and associated with both skin health and cancer pathogenesis.

In dermatology, topical tretinoin is used to treat:

Acne vulgaris – by promoting comedone expulsion, reducing follicular hyperkeratinization, and normalizing skin cell turnover.

Photodamaged skin – by reducing fine wrinkles, pigmentation irregularities, and rough texture, largely through inhibition of UV-induced matrix metalloproteinases that degrade collagen.

Tretinoin does not affect P. acnes bacteria or sebum production but complements antimicrobial therapies like clindamycin for acne.

In oncology, oral tretinoin is used in acute promyelocytic leukemia (APL). APL is driven by a PML-RAR-alpha fusion protein that blocks normal myeloid differentiation. Tretinoin reverses this blockade, promoting the maturation of malignant cells without causing marrow suppression. However, a serious complication known as retinoic acid syndrome (differentiation syndrome) can occur, marked by fever, respiratory distress, and fluid retention.

Clindamycin Phosphate – Warnings & Precautions
You shouldn’t use clindamycin if you’re allergic to it or to similar antibiotics like lincomycin. It’s also not recommended for people with a history of serious gut issues like colitis or inflammatory bowel disease. Some severe reactions, such as skin peeling or life-threatening allergic responses, can occur, so stop using it right away if these happen. It may upset the balance of bacteria in your body and lead to fungal infections, so long-term use should be avoided.

Niacinamide – Warnings & Precautions
Niacinamide is generally safe, but it should be used carefully in people with liver or kidney issues, diabetes, gout, or bleeding problems. High doses should be avoided during pregnancy or breastfeeding unless prescribed. Some side effects include stomach upset, headaches, and skin irritation. It may also interfere with certain medications like statins.

Tretinoin – Warnings & Precautions
Tretinoin shouldn’t be used by those allergic to retinoids or vitamin A. It can make your skin sensitive to the sun, so sunscreen and protective clothing are essential. In rare cases, oral tretinoin can cause serious side effects like breathing problems or brain swelling. Avoid using it on irritated or broken skin and keep it away from eyes.

Clindamycin Phosphate
You shouldn’t use this medicine if you’re allergic to it or similar antibiotics, or if you’ve had serious gut diseases like colitis before. It can cause severe allergic reactions or life-threatening skin problems in rare cases. It may also disturb the balance of bacteria in your gut and lead to fungal infections, so be careful if you use it for a long time. Elderly people and those with asthma or bowel issues should take extra precautions. Even creams or gels can be absorbed into the body, so don’t overuse them.

Clindamycin Phosphate

Pregnancy:

• No congenital abnormalities linked with systemic use in 2nd or 3rd trimester.

• First trimester systemic use may increase risk of major congenital malformations (adjusted OR 1.34).

• Higher risks noted for musculoskeletal defects and septal heart defects.

• Use in first trimester only if clearly needed and benefits outweigh risks.

• Vaginal clindamycin cream studied for preterm birth reduction with mixed results—some trials showed benefits; others showed increased adverse neonatal outcomes.

• Contains benzyl alcohol in parenteral forms, which can be harmful to neonates.

Breastfeeding:

• Clindamycin is excreted into breast milk.

• Potential for serious GI adverse reactions in infants (diarrhea, thrush, antibiotic-associated colitis).

• Use caution; consider alternatives.

• Monitor infants if mother is on clindamycin.

• Unknown if topical or vaginal forms pass into milk; avoid application on breasts to prevent infant ingestion.

Niacinamide (Niacin)

Pregnancy:

• Safe at RDA doses (Pregnancy Category A).

• Higher doses (used for dyslipidemia or pellagra) are Category C.

• High doses not recommended in pregnancy due to lack of safety data.

• Benefits must be weighed against potential risks at higher doses.

Breastfeeding:

• No direct safety studies; manufacturer recommends discontinuing nursing or drug if using lipid-altering doses.

• Adequate dietary intake usually sufficient during lactation.

• Monitor infant for adverse effects if maternal high-dose therapy is necessary.

Tretinoin

Pregnancy:

• Teratogenic and embryotoxic effects demonstrated in animals.

• Human data limited but retinoids are known to increase risks of spontaneous abortion and major fetal abnormalities.

• Topical tretinoin should be used cautiously, avoiding large areas or prolonged use.

• Oral tretinoin has a high risk of birth defects; strict contraception required.

• Pregnancy testing before and during therapy is mandatory.

Breastfeeding:

• Breastfeeding should be stopped prior to oral tretinoin.

• Unknown if topical tretinoin passes into breast milk; systemic absorption from topical use is low.

• Alternative topical agents may be preferred during breastfeeding.

Store this medication in its original container at 68°F to 77°F (20°C to 25°C) and away from heat, moisture and light. Keep all medicine out of the reach of children. Throw away any unused medicine after the beyond use date. Do not flush unused medications or pour down a sink or drain.

1. Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993;329:995-1000.
2. Niaspan (niacin extended-release) tablet package insert. North Chicago, IL: Abbott Laboratories; 2015 Apr.
3. HPS2-THRIVE Collaborative Group. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014;371:203-12.
4. Taylor AJ, Villines TC, Stanck EJ, et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009. Epub ahead of print, doi:10.1056/NEJMoa907569.
5. Lee JMS, Robson MD, Yu LM, et al. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: A randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol 2009;54:1787—94.
6. McKenney JM, et al. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients. JAMA 1994;271:672-7.
7. Vesanoid (tretinoin) capsules package insert. Nutley, NJ: Roche Laboratories Inc.; 2004 Oct.
8. Cleocin (clindamycin injection) package insert. New York, NY: Pharmacia and Upjohn Company; 2020 Feb.
9. Cleocin T (topical clindamycin phosphate) package insert. New York, NY: Pharmacia and Upjohn Company; 2019 Dec.
10. US Food and Drug Administration (FDA). FDA-recognized antimicrobial susceptibility test interpretive criteria. Retrieved March 3, 2020. Available on the World Wide Web at https://www.fda.gov/drugs/development-resources/fda-recognized-antimicrobial-susceptibility-test-interpretive-criteria– LinkOpens in New Tab
11. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, 30th Edition. Retrieved March 3, 2020. Available on the World Wide Web at http://em100.edaptivedocs.net/Login.aspx?returl=GetDoc.aspx%3Fdoc%3DCLSI%20M100%20ED30%3A2020%26scope%3Duser– LinkOpens in New Tab
12. Cleocin (clindamycin granules for soln) package insert. New York, NY: Pharmacia and Upjohn Co; 2020 Feb.
13. Snydman DR, Jacobus NV, McDermott LA, et al. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother 2007;51:1649-1655.
14. Beigi RH, Austin MN, Meyn LA, et al. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004;191:1124-9.
15. Fisher GJ, Wang Z, Datta SC, et al. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997;337:1419-28.
16. Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994;83:10-25.
17. Cleocin (clindamycin capsules) package insert. New York, NY: Pharmacia and Upjohn Co; 2020 Feb.
18. Cleocin (clindamycin vaginal ovules) package insert. New York, NY: Pharmacia and Upjohn Co; 2020 Mar.
19. American Academy of Pediatrics (AAP) Committee on Infectious Diseases. Clostridium difficile infection in infants and children. Pediatrics 2013;131:196-200.
20. Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases Treatment Guidelines 2015. MMWR. 2015;64(3):1-137
21. Health Care Financing Administration. Interpretive Guidelines for Long-term Care Facilities. Title 42 CFR 483.25(l) F329: Unnecessary Drugs. Revised 2015.
22. Colletti RB, Neufeld EJ, Roff NK, et al. Niacin treatment of hypercholesterolemia in children. Pediatrics 1993;92:78-82.
23. Expert Panel: National Cholesterol Education Program. Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89(suppl 2):525-84.
24. Niacinamide. In: Drugs in Pregnancy and Lactation. A Reference Guide to Fetal and Neonatal Risk. Briggs GG, Freeman RK, Yaffe SJ, (eds.) 7th ed., Philadelphia PA: Lippincott Williams and Wilkins; 2005:1140-1
25. Altreno (tretinoin lotion) package insert; Bridgewater, NJ: Valeant Pharmaceuticals North America LLC; 2018 Aug.
26. Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf 2002;25:345-72.
27. Muanda FT, Sheehy O, Berard A. Use of antibiotics during pregnancy and the risk of major congenital malformations: A population based cohort study. Br J Clin Pharmacol 2017; July 19 [Epub ahead of print].
28. Philipson A, Sabath LD, Charles D. Transplacental passage of erythromycin and clindamycin. New Engl J Med 1973;288:1219-21.
29. Weinstein AJ, Gibbs RS, Gallagher M. Placental transfer of clindamycin and gentamicin in term pregnancy. Am J Obstet Gynecol 1976;124:688-91.
30. Lamont RF, Duncan SLB, Mandal D. Intravaginal clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet Gynecol 2003;101:516-522.
31. McGregor JA, French JI, Jones W, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994;170:1048-59.
32. Joesoef MR, Hillier SL, Wiknjosastro G, et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol 1995;173:1527-31.
33. Vermeulen GM, Bruinse HW. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial. Br J Obstet Gynaecol 1999;106:652-7.
34. Evoclin (clindamycin phosphate foam) package insert. Morgantown, WV: Mylan Pharmaceuticals, Inc.; 2018 Apr.
35. Tretinoin capsules package insert. Sellersville, PA: Teva Pharmaceuticals; 2009 Jun.
36. Retin-A Micro (tretinoin gel) package insert. Quebec, Canada: Valeant Pharmaceuticals North America, LLC; 2017 Oct.
37. Mann CF. Clindamycin and breastfeeding. Pediatrics 1980;66:1030-1.
38. American Academy of Pediatrics (AAP) Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001;108(3):776-789.
39. ClindaReach (clindamycin topical pledgets) package insert. Wilmington, MA: DUSA Pharmaceutical, Inc.; 2010 Feb.
40. Clindesse (clindamycin vaginal cream 2%) package insert. St. Louis, MO: Ther-Rx Corporation; 2011 May.
41. Sivapalasingam S, Steigbigel NH. Macrolides, clindamycin, and ketolides. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 7th ed. New York: Churchill Livingstone; 2009:427-48.
42. Cleocin (clindamycin vaginal cream) package insert. New York, NY: Pharmacia and Upjohn Co; 2020 Mar.
43. Niacor (Niacin tablets) package insert. Minneapolis, MN: Upsher-Smith Laboratories, Inc.; 2000 Feb.
44. Tretinoin capsules package insert. Chestnut Ridge, NY: Par Pharmaceutical; 2017 Jan
45. Renova 0.02% (tretinoin cream) package insert; Bridgewater, NJ: Valeant Pharmaceuticals North America LLC; 2013 Jun.